President Reuven Rivlin praises the Israel Institute for Biological Research for its development of an antibody that could be used to treat the coronavirus, calling it “a significant step toward victory.”
Rivlin makes his remarks during a visit to the shadowy Defense Ministry-run research center, which operates in the town of Ness Ziona, south of Tel Aviv, with Defense Minister Naftali Bennett and other defense officials.
Earlier this week, the institute announced that it was the first in the world to isolate an antibody that appeared to be specifically well-suited to combating the COVID-19 virus. Though the antibody was only tested against the virus in a Petri dish, researchers believe it could be used to develop a treatment for the disease — not a vaccine for it.
“The process is complicated and will take time, but every breakthrough of yours is a significant step toward victory,” Rivlin says.
“I fully hope that good news will come out of Zion, good news that will allow us to ensure the health of anyone who’s at risk, that we’ll be able to let grandparents and all of the at-risk populations out from a difficult quarantine,” he says.
The president’s office says he also recommended to Bennett and the heads of the institute to consider opening a vaccine factory in the southern town of Yeruham in order to help it develop and grow economically.
— Judah Ari Gross
President Reuven Rivlin (R) visits the Israel Institute for Biological Research in Ness Ziona on May 7, 2020. (Kobi Gideon/GPO)
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel